Biofidelity’s Aspyre Lung Delivers Accurate Molecular Diagnostics for NSCLC Variants
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Lung Cancer, Molecular Diagnostics |
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Cancer, Company News, Molecular Diagnostics |
OncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read MorePosted by Andy Lundin | Nov 29, 2024 | Cancer, Miscellaneous, Point-of-Care |
The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MorePosted by Chris Wolski | Nov 28, 2024 | Breast |
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read More